18 Nov 2020 | All | Samsung Bioepis, Biogen | Samsung Bioepis and Biogen announce the FDA has accepted for review the BLA for SB11 (proposed ranibizumab biosimilar).

12 Nov 2020 | All | Samsung Bioepis | Samsung Bioepis announces one-year results from Ph III study of SB...

August 18, 2020

19 Aug 20 | CA | Sandoz | Sandoz Canada announces it has entered an agreement with the Pan-Canadian Pharmaceutical Alliance (pCPA) regarding biosimilar medicines Ziextenzo® (biosimilar pegfilgrastim) and Riximyo® (biosimilar rituximab). Both products were approved by H...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags